跳至主要内容
临床试验/IRCT138805061141N3
IRCT138805061141N3已完成1 期

Comparison of micro-dose human chorionic gonadotropin (hCG) with HMG in PCOS patients with previous Clomiphene Citrate (CC)-resistant anovulation

Reproductive Medicine Research Center, Royan Institute, ACECR0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 30 years(—)
性别
Female

入选标准

  • age under 30 years, primary infertility, PCOS diagnosed by the Rotterdam criteria, by two of the following three features: 1) oligo or anovulation, 2) clinical and/or biochemical signs of hyper androgenism, or 3) polycystic ovaries, previously documented dominant follicle or follicles (R12 mm mean diameter) on transvaginal Ultrasound follicular monitoring, Normal uterine cavity and patent tubes by either hysterosalpingogram or laparoscopy and hysteroscopy, normal fasting glucose and insulin levels, normal serum prolactin, and thyroid stimulating hormone, Estradiol, Progesterone, FSH and dehydroepiandrosterone sulfate levels, normal semen analysis by World Health Organization criteria

排除标准

  • previous history of IVF or ICSI treatments, history of hormonal treatment within three month prior to admission (Except OCP, progesterone), history of ovarian cutter or Ovarian drilling, BMI higher than 30, presence of ovarian cyst (more than 30 mm) during third cycle ultrasound

研究者

发起方
Reproductive Medicine Research Center, Royan Institute, ACECR

相似试验

Micro dose HCG in PCOS patients with previous... | 临床试验